Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 327

1.

Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.

Wickham R.

Clin J Oncol Nurs. 2007 Jun;11(3):361-76. Review.

PMID:
17623621
[PubMed - indexed for MEDLINE]
2.

The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.

Smith EM, Cohen JA, Pett MA, Beck SL.

Cancer Nurs. 2010 May-Jun;33(3):173-83. doi: 10.1097/NCC.0b013e3181c989a3.

PMID:
20357656
[PubMed - indexed for MEDLINE]
3.

Evaluation and management of peripheral neuropathy in diabetic patients with cancer.

Visovsky C, Meyer RR, Roller J, Poppas M.

Clin J Oncol Nurs. 2008 Apr;12(2):243-7. doi: 10.1188/08.CJON.243-247. Review.

PMID:
18390460
[PubMed - indexed for MEDLINE]
4.

Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy.

Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C.

Clin J Oncol Nurs. 2007 Dec;11(6):901-13. Review.

PMID:
18063548
[PubMed - indexed for MEDLINE]
Free Article
5.

Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.

Amara S.

Ann Pharmacother. 2008 Oct;42(10):1481-5. doi: 10.1345/aph.1L179. Epub 2008 Aug 12. Review.

PMID:
18698011
[PubMed - indexed for MEDLINE]
6.

Clinical challenges: chemotherapy-induced peripheral neuropathy.

Paice JA.

Semin Oncol Nurs. 2009 May;25(2 Suppl 1):S8-19. doi: 10.1016/j.soncn.2009.03.013. Review.

PMID:
19447319
[PubMed - indexed for MEDLINE]
7.

Chemotherapy-induced neuropathy.

Bhagra A, Rao RD.

Curr Oncol Rep. 2007 Jul;9(4):290-9. Review.

PMID:
17588354
[PubMed - indexed for MEDLINE]
8.

Chemotherapy-induced peripheral neurotoxicity.

Cavaletti G, Marmiroli P.

Expert Opin Drug Saf. 2004 Nov;3(6):535-46. Review.

PMID:
15500413
[PubMed - indexed for MEDLINE]
9.

[Chemotherapy-induced peripheral neuropathy].

Noguchi E, Maeda Y.

Gan To Kagaku Ryoho. 2011 Nov;38(11):1773-6. Japanese.

PMID:
22083183
[PubMed - indexed for MEDLINE]
10.

Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice.

Binner M, Ross D, Browner I.

Oncol Nurs Forum. 2011 Jul;38(4):448-54. doi: 10.1188/11.ONF.448-454.

PMID:
21708535
[PubMed - indexed for MEDLINE]
11.

Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.

Dunlap B, Paice JA.

J Support Oncol. 2006 Sep;4(8):398-9. No abstract available.

PMID:
17004514
[PubMed - indexed for MEDLINE]
12.

Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.

Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F.

Semin Oncol. 2006 Feb;33(1):15-49. Review.

PMID:
16473643
[PubMed - indexed for MEDLINE]
13.

Docetaxel-related side effects and their management.

Baker J, Ajani J, Scotté F, Winther D, Martin M, Aapro MS, von Minckwitz G.

Eur J Oncol Nurs. 2008 Jul;12(3):253-68. doi: 10.1016/j.ejon.2008.03.006. Epub 2008 May 22. Review. Erratum in: Eur J Oncol Nurs. 2008 Dec;12(5):479. Dosage error in article text.

PMID:
18501674
[PubMed - indexed for MEDLINE]
14.

Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments.

Kiser DW, Greer TB, Wilmoth MC, Dmochowski J, Naumann RW.

Oncol Nurs Forum. 2010 Nov;37(6):758-64. doi: 10.1188/10.ONF.758-764.

PMID:
21059587
[PubMed - indexed for MEDLINE]
15.

Background noise: the experience of chemotherapy-induced peripheral neuropathy.

Bakitas MA.

Nurs Res. 2007 Sep-Oct;56(5):323-31.

PMID:
17846553
[PubMed - indexed for MEDLINE]
16.

Chemotherapy-induced peripheral neurotoxicity.

Cavaletti G, Marmiroli P.

Nat Rev Neurol. 2010 Dec;6(12):657-66. doi: 10.1038/nrneurol.2010.160. Epub 2010 Nov 9. Review.

PMID:
21060341
[PubMed - indexed for MEDLINE]
17.

The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.

Smith EM, Beck SL, Cohen J.

Oncol Nurs Forum. 2008 Jan;35(1):96-102. doi: 10.1188/08.ONF.96-102. Review.

PMID:
18192158
[PubMed - indexed for MEDLINE]
18.

Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.

Argyriou AA, Zolota V, Kyriakopoulou O, Kalofonos HP.

J BUON. 2010 Jul-Sep;15(3):435-46. Review.

PMID:
20941808
[PubMed - indexed for MEDLINE]
19.

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Mukai H, Katsumata N, Sunada Y, Watanabe T, Hausheer FH.

Support Care Cancer. 2009 Dec;17(12):1483-91. doi: 10.1007/s00520-009-0613-7. Epub 2009 Mar 28.

PMID:
19330359
[PubMed - indexed for MEDLINE]
20.

Empowering nurses to advocate for improved patient care.

Held-Warmkessel J.

ONS News. 2006;21(8 Suppl):53-4. No abstract available.

PMID:
16925152
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk